Literature DB >> 7719502

Posterior annuloplasty in the surgical treatment of mitral insufficiency.

A Pellegrini1, E Quaini, T Colombo, M Lanfranchi, C Russo, E Vitali.   

Abstract

One hundred and twenty-nine patients underwent posterior mitral annuloplasty with a Gore-Tex tube for mitral regurgitation between January 1982 and June 1991. The hospital mortality was 1.5% (CL = 0.5%-2.5%). The overall survival of hospital survivors was 96.5% +/- 2.7% at five and 86.2% +/- 7.6% at nine years, freedom from cardiac death was 99.1% +/- 0.9% and 95.2% +/- 3.9%, respectively. The actuarial freedom from embolism was 96.1% +/- 2.3% at five and 88.5% +/- 5.5% at nine years. The freedom from endocarditis (one patient) was 100% and 92.6 +/- 7.1%, respectively. Reoperation was necessary in six cases between one and 72 months after the operation (mean 38.5 +/- 30.5 months). The etiology of the valvular insufficiency was rheumatic in all reoperated cases. The freedom from reoperation was 94.1% +/- 3.2% at five and 87.2% +/- 5.6% at nine years. There was no mortality at reoperation. Of the 117 patients alive at the end of follow up and not requiring reintervention, 113 (96.6%) showed good functional improvement and were in NYHA functional class I or II. We conclude that both the immediate and long-term results of reconstructive surgery using the technique of inserting a half-ring on the posterior mitral annulus compare favorably with those obtained using other annuloplasty methods.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7719502

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  2 in total

1.  Posterior mitral annuloplasty with a flexible linear reducer.

Authors:  Hitoshi Matsumoto; Ryuzo Sakata; Yoshifumi Iguro; Hiroshi Masuda; Tamahiro Kinjo; Gouichi Yotsumoto; Kenichi Arata; Kazuhisa Matsumoto
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-09

2.  The viable mitral annular dynamics and left ventricular function after mitral valve repair by biological rings.

Authors:  Farideh Roshanali; Ali Vedadian; Saeed Shoar; Saleh Sandoughdaran; Mohammad Naderan; Mohammad Hossein Mandegar
Journal:  Int Cardiovasc Res J       Date:  2012-12-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.